Further immunotherapy analysis demonstrated that high levels of GPR55 were not only correlated with higher TIS, which is an objective indicator of immune response, but were also associated with better response rates to immunotherapy in HCC. The gene discussed is GPR55; the disease is hepatocellular carcinoma.